研飞客户端支持数万种期刊查询，助你在阅读和写作中随时了解期刊动态
Rheumatic Disease Clinics of North America
| 短名 | Rheum. Dis. Clin. North. Am. |
| Journal Impact | 2.70 |
| 国际分区 | RHEUMATOLOGY(Q2) |
| 期刊索引 | SCI Q4中科院 4 区 |
| ISSN | 0889-857X, 1558-3163 |
| h-index | 100 |
| 国内分区 | 医学(4区)医学风湿病学(4区) |
《Rheumatic Disease Clinics of North America》致力于为您提供风湿病患者管理的最新趋势和进展，帮助您为治疗方案的选择打下坚实的基础。每期（2月、5月、8月和11月）聚焦于风湿病学的一个特定主题，内容由经验丰富的编辑团队精心编排。主题涵盖骨关节炎、类风湿性关节炎、晶体疾病、肌肉骨骼检查、骨骼疾病、免疫缺陷状态、狼疮、神经肌肉疾病、疼痛疾病、硬皮病、血管炎、儿科、疗法、治疗指南和治疗方式等。
期刊主页投稿网址阅读文献时，研飞即可帮你快速了解期刊，查询影响因子与分区，智能高亮期刊预警！
| 涉及主题 | 医学内科学生物病理免疫学疾病遗传学重症监护医学心理学外科精神科化学 |
| 出版信息 | 出版商: W.B. Saunders，出版周期: Quarterly，期刊类型: journal |
| 基本数据 | 创刊年份: 1987，原创研究文献占比: 100.00%，自引率:0.00%， Gold OA占比: 4.62% |
| 平均审稿周期 | 网友分享经验：>12周，或约稿 |
| 平均录用比例 | 网友分享经验：较易 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
手工熬夜修改参考文献？研飞自动匹配期刊，一键轻松成稿，支持 Word/WPS
点击下方按钮，免费开启试用！
最新文章
Imaging in Rheumatology
2024-9-1
Imaging Modalities in Myositis
2024-9-1
Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis
2024-9-1
Imaging Challenges and Developments in Large-vessel Vasculitis
2024-9-1
New Developments in Imaging in Crystalline Arthritis
2024-9-1
Axial Imaging in Spondyloarthritis
2024-9-1
Cardiac MRI in Rheumatic Disease
2024-8-1
Imaging Revolutions in Modern Rheumatology
2024-8-1
Imaging of the Major Salivary Glands in Rheumatic Disease
2024-8-1
Central Nervous System Imaging in Rheumatic Diseases
2024-8-1
Imaging in Juvenile Idiopathic Arthritis
2024-8-1
Imaging in Inflammatory Bowel Disease
2024-8-1
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease
2024-6-26
Copyright
2024-6-26
Highlights of Interdisciplinary Care in Rheumatology
2024-6-26
Prospects of Disease-Modifying Osteoarthritis Drugs
2024-6-26
Connective Tissue Disease Associated Interstitial Lung Disease
2024-6-26
Pulmonary Hypertension Associated with Connective Tissue Disease
2024-6-26
Contents
2024-6-26
Contributors
2024-6-26
Imaging of Rheumatic Diseases Affecting the Lower Limb
2024-6-26
Imaging of Pulmonary Manifestations of Connective Tissue Disease
2024-6-26
Newer Immunosuppressants for Rheumatologic Disease
2024-6-26
Systemic Diseases and Heart Block
2024-6-26
The Role of Psychology in Pediatric Rheumatic Diseases
2024-6-26
Beyond Coronary Artery Disease
2024-6-26
Forthcoming Issues
2024-6-26
Foreword
2024-6-26
Highlights of Interdisciplinary Care in Rheumatology
2024-6-26
Rheumatic Immune-related Adverse Events
2024-4-24
Forthcoming Issues
2024-4-24
Foreword
2024-4-24
Contents
2024-4-24
Immune Checkpoint Inhibitor-induced Sicca Syndrome
2024-4-24
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica
2024-4-24
Contributors
2024-4-24
Copyright
2024-4-24
The Current and Future of Biomarkers of Immune Related Adverse Events
2024-3-12
The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis
2024-3-12
Immune Checkpoint Inhibitor-induced Myositis
2024-3-12
Imaging in Rheumatic Immune-related Adverse Events
2024-3-8
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy
2024-3-8
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
2024-3-8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
2024-3-5
Rheumatic Immune-Related Adverse Events: Current Clinical Imperatives Underpin Future Novel Insights
2024-2-23
Patient Voices in Rheumatic Immune-related Adverse Events
2024-2-22
De Novo Connective Tissue Disorders as Immune-Related Adverse Events
2024-2-1
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune-Related Adverse Events
2024-2-1
Immunotherapy Toxicity Management in Clinical Practice
2024-2-1
Preexisting Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression
2024-2-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远